Referencias Bibliográficas
1. Grupp, S. A., et al. (2013). Chimeric antigen receptor–modified T cells for acute lymphoid leukemia. New England Jour...
Referencias Bibliográficas 1. Grupp, S. A., et al. (2013). Chimeric antigen receptor–modified T cells for acute lymphoid leukemia. New England Journal of Medicine, 368(16), 1509-1518. 2. Maude, S. L., et al. (2014). Chimeric antigen receptor T cells for sustained remissions in leukemia. New England Journal of Medicine, 371(16), 1507-1517. 3. Lee, D. W., et al. (2015). T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. The Lancet, 385(9967), 517-528.
Compartir